KELLEE ENGLISH: Open Payments
NPI 1164985644 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,799 in 139 payments from 23 companies in 2025. Trend: 2023 $1,703 · 2024 $2,671 · 2025 $2,799
Food & beverage: $2,799
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 13 | $362 |
| Janssen Biotech, Inc. | 17 | $347 |
| ABBVIE INC. | 21 | $306 |
| Regeneron Healthcare Solutions, Inc. | 8 | $241 |
| Novartis Pharmaceuticals Corporation | 6 | $238 |
| GENZYME CORPORATION | 7 | $179 |
| Lilly USA, LLC | 6 | $161 |
| Incyte Corporation | 16 | $137 |
| Organon LLC | 8 | $122 |
| PFIZER INC. | 5 | $96 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, OPZELURA, RINVOQ, SKYRIZI, VTAMA, TALTZ.
Industry payments across AZ — which companies pay providers there.
